Filter
564
Filtered Results: 564
Text search:
L.
Xu
Featured
Recommendations
55
New Publications
77
Language
Document type
No document type
180
Studies & Reports
160
Guidelines
146
Fact sheets
28
Manuals
26
Strategic & Response Plan
11
Infographics
6
Training Material
4
Situation Updates
2
Brochures
1
Countries / Regions
Global
25
Russia
25
India
16
Brazil
15
Latin America and the Carribbean
13
Middle East and North Africa
12
Vietnam
12
Germany
9
Kenya
8
Western and Central Europe
8
Ukraine
7
Syria
7
Peru
7
South Africa
7
Yemen
7
Indonesia
7
Nepal
6
China
6
Rwanda
6
Africa
6
Cambodia
6
Asia
6
Spain
6
Myanmar / Burma
6
Mozambique
5
Eastern Europe and Central Asia
5
Eastern Europe
5
Chile
4
Laos
4
West and Central Africa
4
France
4
Angola
4
Ghana
3
Benin
3
Malawi
3
Philippines
3
Italy
3
Guinea-Bissau
3
Congo, Democratic Republic of
3
Uganda
3
Namibia
3
Sudan
3
Ecuador
3
Cameroon
2
Nigeria
2
Senegal
2
South–East Asia Region
2
United Kingdom
2
Portugal
2
East and Southern Africa
2
Argentina
2
Botswana
2
Zambia
2
South Sudan
2
Tajikistan
1
Switzerland
1
Colombia
1
Thailand
1
Mexico
1
Lesotho
1
Turkey
1
Sierra Leone
1
Kazakhstan
1
Kyrgyzstan
1
Zimbabwe
1
Austria
1
Mongolia
1
Armenia
1
Venezuela
1
Tanzania
1
Bolivia
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
194
Clinical Guidelines
35
Women & Child Health
28
Public Health
27
Key Resources
11
Pharmacy & Technologies
6
Capacity Building
1
Toolboxes
COVID-19
174
Planetary Health
52
Mental Health
34
HIV
27
TB
25
NTDs
21
NCDs
16
Pharmacy
14
Health Financing Toolbox
14
Caregiver
10
AMR
9
Rapid Response
8
Refugee
8
Global Health Education
8
Disability
7
Zika
7
Ebola & Marburg
5
Cholera
2
Natural Hazards
1
Social Ethics
1
Conflict
1
Past quantitative research on health financing has focused mostly on the level and distribution of total expenditure, with little emphasis on the specific role of public funds, despite their known importance for universal health coverage (UHC). Health Accounts data do not disaggregate public expendi...
Accessed Febr. 6, 2020
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
This document provides guidance to EU/EEA Member States on environmental cleaning in healthcare and non-healthcare settings during the COVID-19 pandemic.
La presente publicación describe la evidencia científica publicada respecto a la hipertensión como factor pronóstico en pacientes con COVID-19. Se identificó una revisión sistemática que evaluó diferentes desenlaces de pronóstico en pacientes con hipertensión y diagnóstico confirmado de C...
As of 15 May 2020, more than 4 million confirmed cases of COVID-19, including more than 285,000 deaths have been reported to WHO. The risk of severe disease and death has been highest in older people and in persons with underlying noncommunicable diseases (NCDs), such as hypertension, cardiac diseas...
Policy Brief November 2021 Available in English, Spanish and Portuguese
The COVID-19 pandemic has fueled the ongoing antimicrobial resistance (AMR) global crisis due to the increase in the use of antibiotics to treat COVID-19 patients, disruptions to infection prevention and control practices in o...
Guidelines for the treatment of human African trypanosomiasis. Web Annex A. Commissioned by WHO Cochrane Response
PLoS Negl Trop Dis 16(11): e0010885. https://doi.org/10.1371/journal.pntd.0010885
HAT diagnosis in non-endemic countries is rare and can be challenging, but alertness and
surveillance must be maintained to contribute to WHO’s elimination goals. Early detection is
particularly important as it co...
Prevention, identification and management of health worker infection in the context of COVID-19
recommended
This document provides interim guidance on the prevention, identification and management of health worker infection in the context of COVID-19. It is intended for occupational health departments, infection prevention and control departments or focal points, health facility administrators and public ...
Scientific Brief 9 July 2020
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
Scientific Brief, 30 June 2020
Der Artikel "Händedesinfektion unter den Bedingungen der SARS-CoV-2-Pandemie" war am 4.5.2020 online vorab erschienen und ist nun in der regulären Ausgabe des Epidemiologischen Bulletins 19/2020 zu finden.
Water, sanitation, hygiene, and waste management for SARS-CoV-2, the virus that causes COVID-19
recommended
Updated Interim guidance 29 July 2020
The provision of safe water, sanitation and waste management and hygienic conditions is essential for preventing and for protecting human health during all infectious disease outbreaks, including of coronavirus disease 2019 (COVID-19). Ensuring evidenced-based ...
Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-...
